FDA Inspection 1274854 — Joanna Gozdzik, M.D
The FDA completed an inspection of Joanna Gozdzik, M.D on June 6, 2025 in Katowice. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 6, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Katowice (Poland)
Additional Details
Clinical Investigator (CI)